8-K/A: Current report
Published on August 31, 2009
Securities
and Exchange Commission
Washington,
D.C. 20549
FORM
8-K/A
Amendment
No. 1
Current
Report
Pursuant
To Section 13 or 15(d) Of
The
Securities Exchange Act of 1934
Date of
Earliest Report Event: August 24, 2009
Versa Card,
Inc.
(Formerly
“Intrepid Global Imaging 3D, Inc.”)
(Exact Name of Registrant As Specified in Its Charter)
|
Delaware
|
000-27407
|
98-0187705
|
|
(State
Or Other Jurisdiction of Incorporation)
|
(Commission
File Number)
|
(IRS
Employer Identification No.)
|
5225
Katy Freeway
Suite
600
Houston,
Texas 77007
(Address
of principal executive office) (Postal Code)
(713)
816-7303
(Registrant’s
telephone number)
ITEM
8.01 OTHER
EVENTS.
The
purpose of this amendment is to reflect the terms of the Amended and Restated
Medical Services Agreement (the “AMSA”) entered into between Versa Card, Inc.
(the “Company”) and Northshore Orthopedics, Assoc., a Texas professional
association (“NSO”) on August 28, 2009, effective as of August 24, 2009, which
AMSA amended and restated in its entirety the Medical Services Agreement
previously entered into by the parties. The AMSA provides for the
opening of the Company’s first spine injury treatment center in Houston,
Texas. Pursuant to the AMSA, NSO will operate as an independent
contractor for the Company to provide medical diagnostic services for evaluation
and treatment of patients with spine injuries. The AMSA has a term of
three years, and thereafter will automatically renew for three year
periods. NSO is owned by the Company’s Chief Executive Officer,
William Donovan, M.D.
1
ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS
(d)
Exhibits
|
Exhibit
No.
|
Description |
|
99.1
|
Press
Release dated August 26, 2009 (Incorporated by reference from Form 8-K
filed with the SEC on August 26,
2009)
|
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has
duly caused this report on Form 8-K to be signed on its behalf by the
undersigned hereunto duly authorized.
|
VERSA
CARD, INC.
|
|||
|
|
|
/s/ William Donovan, M.D. | |
| By: William Donovan, M.D. | |||
|
Date: August
28, 2009
|
Chief
Executive Officer
|
||
2